Overview
Yury Rozenman serves as Executive Vice President at TytoCare [1]. Rozenman has worked for over two decades across healthcare and life sciences, including roles in drug discovery, clinical development, and pharmaceutical commercial growth, with leadership experience in marketing and business development across large pharma, medical device, digital health, digital therapeutics, and patient engagement [2]. Rozenman's recent professional positions include Strategic Advisor at Rune Labs [4], Advisor at Ada Health [5], and General Manager at Kaia Health [7]. Prior roles include Senior Vice President of Business Development at Propeller Health [8], Global Partner Leader for Healthcare & Life Sciences at Amazon Web Services [9], and Head of Business Development for Fitbit Health Solutions [10]. Rozenman holds a BS in Chemistry from the University of Illinois Chicago [11].
Profile introduction
For over two decades, I’ve worked across healthcare and life sciences — from early drug discovery through clinical development to pharma commercial growth. I’ve led marketing and business development organizations spanning large pharma, med tech drug delivery and wearables, digital health and digital therapeutics, and patient engagement — bringing science, technology, and partnerships together to deliver real impact for patients
Career history
- Executive Vice PresidentJul 2026 to presentTytoCare
- Strategic AdvisorFeb 2026 to presentRune Labs
- AdvisorOct 2024 to presentAda Health
- Senior Vice President Business DevelopmentMar 2024 to Oct 2024Ada Health
- General ManagerOct 2024 to Feb 2026Kaia Health
- Senior Vice President Business DevelopmentOct 2021 to Mar 2024Propeller Health
- Global Partner Leader, Healthcare & Life SciencesMar 2020 to Oct 2021Amazon Web Services (AWS)
- Head of Business Development Fitbit Health SolutionsSep 2018 to Apr 2020Fitbit
- Strategic AdvisorRune
Education
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.